GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » PB Ratio

Celadon Pharmaceuticals (LSE:CEL) PB Ratio : 17.86 (As of May. 01, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-01), Celadon Pharmaceuticals's share price is €1.00. Celadon Pharmaceuticals's Book Value per Share for the quarter that ended in Jun. 2023 was €0.06. Hence, Celadon Pharmaceuticals's PB Ratio of today is 17.86.

The historical rank and industry rank for Celadon Pharmaceuticals's PB Ratio or its related term are showing as below:

LSE:CEL' s PB Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 520
Current: 17.5

During the past 4 years, Celadon Pharmaceuticals's highest PB Ratio was 520.00. The lowest was 0.00. And the median was 0.00.

LSE:CEL's PB Ratio is ranked worse than
97.3% of 963 companies
in the Drug Manufacturers industry
Industry Median: 1.97 vs LSE:CEL: 17.50

During the past 12 months, Celadon Pharmaceuticals's average Book Value Per Share Growth Rate was -73.30% per year.

Back to Basics: PB Ratio


Celadon Pharmaceuticals PB Ratio Historical Data

The historical data trend for Celadon Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals PB Ratio Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22
PB Ratio
- - - 3.53

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial - - 4.55 3.53 26.61

Competitive Comparison of Celadon Pharmaceuticals's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celadon Pharmaceuticals's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's PB Ratio falls into.



Celadon Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Celadon Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=1.00/0.056
=17.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Celadon Pharmaceuticals  (LSE:CEL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Celadon Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Celadon Pharmaceuticals (LSE:CEL) Business Description

Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines